Jellyfish Dermatitis, Jellyfish Venoms
Conditions
Keywords
jellyfish, jellyfish venom, jellyfish dermatitis, jellyfish stings, Ipomea pes-caprae
Brief summary
This is an open label, prospective, test of superiority efficacy trial of Ipomea pes-caprae ointment as an add-on therapy in patient with jellyfish dermatitis. Each patient will receive standard medical treatment depend on the severity of the disease. The doctor will divide the dermatitis area of each patient into two parts. Ipomea pes-caprae ointment will be applied as an add-on therapy to the test area, while the ointment will not be applied to the control area. Patients will be asked to come for follow up 6 times in the 28-days study period. Primary objective is to compare the healing time of dermatitis in both areas.
Detailed description
The Test area and Control area are allocated in each participant. We use the Internal Control fashion. The healing time of each area will be collected as an outcome measure.
Interventions
DRUGIpomea pes-caprae ointment
Ipomea pes-caprae ointment will be applied twice a day as an add-on therapy.
Sponsors
Mahidol University
Study design
Allocation
NON_RANDOMIZED
Intervention model
SINGLE_GROUP
Primary purpose
TREATMENT
Masking
NONE
Eligibility
Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No
Inclusion criteria
* clinical diagnosis of jellyfish dermatitis * total lesion area is more than 4 square centimeter
Exclusion criteria
* expose to jellyfish more than 7 days * severe systemic reaction to jellyfish * allergy to Ipomea pes-caprae or the component of the ointments
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Healing time of the Jellyfish dermatitis lesion (days) | Follow up to 28 days |
Countries
Thailand
Outcome results
None listed